Archive: 31/07/2018

Azedra approved for rare adrenal tumors

(HealthDay)—Azedra (iobenguane) has been approved by the U.S. Food and Drug Administration to treat people 12 and older with rare adrenal gland tumors that can't be surgically removed and have spread beyond the original ...

page 1 from 7